MedTrace Logo

The Effect of Oxytocin on the Consolidation of Trauma-Associated Memories

NCT03875391 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 217

Last updated 2023-04-04

No results posted yet for this study

Summary

The purpose of the study is to examine whether oxytocin and certain polygenic risk scores affect the development of intrusive memories, a cardinal symptom of PTSD.

Conditions

  • Intrusive Memories
  • PTSD

Interventions

DRUG

Oxytocin

Drug: Oxytocin nasal spray

DRUG

Placebo

Drug: Placebo nasal spray

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Stefan Roepke, Prof · Charité

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-06
Primary Completion
2020-12-31
Completion
2021-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03875391 on ClinicalTrials.gov